Atropos Health

Atropos Health provides its clients with insights and reports into clinical queries based on anonymized patient records. The company refers to this as their “prognostogram informatics consult”, which has a 24-hour turnaround time. The company is working on a similar consult service for oncology where treatment pathways will also be suggested based on previous patient data. Its main clients are physicians. 

In October 2023, Atropos Health launched the Geneva OS (Generative Evidence Acceleration Operating System) and ChatRWD (Real World Data) application, aimed at helping healthcare and life sciences leaders advance evidence generation. The new offering allows non-technical users to generate publication grade observational research studies using real world data from the Atropos Evidence Network. The company claimed that the new offering can expedite decision-making, generate evidence in minutes instead of weeks to months, and result in cost savings while not affecting clinical outcomes.

Key customers and partnerships

In June 2024, the company partnered with Norstella, an intelligence solution provider, to expand the Atropos Evidence Network. Through this partnership, Norstella’s platform was used to expand the adoption of Atropos Health's GenAI platform GENEVA OS.

Most recently, in December 2024, the company partnered with QuantHealthan AI-powered drug development platform, to leverage over 300 million patient records for improving clinical trial predictions. Through Atropos Health's Evidence Network, QuantHealth planned to deploy AI models at the point of care to match patients with clinical trials based on current and future eligibility status, as well as their likelihood to benefit from the trial.

In January 2024 the company partnered with healthcare data platform Arcadia to integrate Atropos' evidence generation capability into Arcadia's data platform, enabling value-based healthcare services and decision-making. The partnership allows Arcadia’s clients to apply Atropos’s suite of tools, which turn medical data into individual evidence supporting comprehensive patient care and performance in value-based care models. 

Also in January 2024, the company partnered with Google Cloud to accelerate real-world evidence generation for healthcare systems. Through the partnership, Atropos’ GENEVA OS platform was integrated with Google Cloud's Healthcare Data Engine (HDE) and BigQuery. This enabled company's using Atropos' services to simplify access to data, streamline analytics, and democratize insights.

The company also partnered with SEQESTER in December 2023 to save time, money, and accelerate drug development. Through the partnership, SEQESTER incorporated Atropos' solution to its own, allowing SEQESTER to deliver real-time and real-world data layered in AI to accelerate drug discovery.

In June 2023, the company partnered with healthcare data ecosystem provider Datavant to exchange patient-level data. Through the partnership, Atropos Health users gained access to Datavant’s services, while Datavant’s ecosystem gained access to the Atropos Evidence Platform. The partnership also enabled Atropos Health to grade data present in Datavant’s ecosystem to assign a “Real World Data Score,” based on the quality of data with regard to size, completeness, longitudinality, and level of standardization and a “Real World Fitness” score, based on the data’s real-world applications. Additionally, the partnership allowed for the conversion of Datavant’s ecosystem data into real-world evidence through Atropos Health’s “Green Button Informatics Consult Service,” which creates publication-grade analytics in 48 hours.